arrow
S

Stephan Forchhammer

universitätsklinikum tübingen
H指数:14
被引数:701

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Integrated histopathological and molecular diagnostics reveal substantial diagnostic shifts in pediatric melanocytic tumors

整合组织病理学和分子诊断揭示儿童黑色素细胞肿瘤中显著的诊断转变

2026-11-050
OAAI
Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years

原发性黑色素瘤假阴性诊断患者的生命损失年数。一项涉及9063例患者、为期28年的德国中央恶性黑色素瘤登记研究的回顾性研究

2026-07-020
OAAI
Copy Number Analysis in Congenital Nevi: Concordance and Diagnostic Limitations of aCGH, sWGS, and Methylation Sequencing

先天性痣中的拷贝数分析:aCGH、sWGS和甲基化测序的一致性与诊断局限性

2026-06-040
OA
Myeloid sarcoma shows a high frequency of mutations activating the MAPK/ERK pathway and association with clonal hematopoiesis

髓系肉瘤显示出高频率的MAPK/ERK通路激活突变,并与克隆性造血相关。

2025-09-040
OAAI
The subcellular distribution of phosphorylated Y-box-binding protein-1 at S102 in colorectal cancer patients, stratified by KRAS mutational status and clinicopathological features

在结直肠癌患者中,根据KRAS突变状态和临床病理特征进行分层的磷酸化Y-box结合蛋白-1在S102位点的亚细胞分布

2025-05-260
OAAI
Risk stratification using the Merlin Assay (CP-GEP) in an independent cohort of 930 patients with clinical stage I/II melanoma who did not undergo sentinel lymph node biopsy

使用Merlin Assay (CP-GEP)对未进行前哨淋巴结活检的930例临床Ⅰ/Ⅱ期黑色素瘤患者独立队列进行风险分层

2025-05-010
OAAI
Expression of the tumor antigens NY-ESO-1, tyrosinase, MAGE-A3, and TPTE in pediatric and adult melanoma: a retrospective case control study
2024-06-182
OAAI
Histopathologic regression in patients with primary cutaneous melanoma undergoing sentinel lymph node biopsy is associated with favorable survival and, after metastasis, with improved progression-free survival on immune checkpoint inhibitor therapy: A singleinstitutional cohort study

接受前哨淋巴结活检的原发性皮肤黑色素瘤患者的组织病理学消退与良好的生存率相关,转移后,免疫检查点抑制剂治疗可改善无进展生存率: 一项单机构队列研究

2024-04-012
OAAI